Merz Pharma

Merz Pharma GmbH & Co. KGaA is a privately-held pharmaceutical company based in Frankfurt, Germany with affiliates across Europe, as well as the US, Canada, Mexico, Brazil and Asia Pacific and regional headquarters in Singapore and North Carolina, USA.
The company is active in research, development and distribution of products in the areas of aesthetic medicine and neurologically induced movement disorders. In German-speaking countries, the Merz consumer products business, Merz Consumer Care, is a provider of health, wellness and beauty products with its tetesept and Merz Spezial brands.
Today, Merz’s global businesses are focused on the areas of medical aesthetics and neurotoxin therapy, supported by regional brands in both the prescription medicine and consumer health and beauty sectors. Key brands in the Merz Aesthetics portfolio include Belotero, Radiesse, Cellfina, Ultherapy, Botulinum Toxin and Neocutis (US only).
History.
The company was founded in 1908 in Frankfurt, Germany by a 24-year old chemist named Friedrich Merz, and is still owned by the fourth generation of the Merz family.
1908 – Company founded
1911 – Introduction of first topical contraceptive Patentex
1953 – Launch of anti-wrinkle moisturizing cream Placentubex
1964 – Development of Merz Spezial Dragees from 18 different active ingredients
1965 – Introduction of tetesept bath medicine
1968 – Launch of Placentubex Foaming Mask
2002 – Introduction of Memantine for the treatment of Alzheimer’s disease
2005 – Merz launches a uniquely purified Botulinum Toxin
2010 – Acquisition of Bioform and its flagship product RADIESSE
2013 – Acquisition of Anteis and its range of dermal fillers, Belotero
2013 – Acquisition of Swiss skincare company Neocutis
2014 – Acquisition of the Ulthera System, the first ultrasound platform device with FDA clearance
2015 – Launch of Radiesse (+) Lidocaine in the US market
2015 – Establishment of Asia Pacific regional Headquarters in Singapore
2016 – Acquisition of ON Light Sciences with its flagship product DeScribe
2016 – Launch of the Cellfina System in the US, minimally-invasive cellulite treatment
2018 – Launch of Belotero Lips
2019 – Launch of Belotero Revive
2020 – Reorganization into three businesses: Merz Aesthetics, Merz Therapeutics, and Merz Consumer Care